Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DAPK-IN-2 (WAY-380496) is a DAPK inhibitor. DAPK-IN-2 has potential anticancer activity, regulates autophagy and can be used to study cerebral infarction and ischemic diseases.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 195.00 | |
5 mg | In stock | $ 430.00 | |
10 mg | In stock | $ 636.00 | |
25 mg | In stock | $ 987.00 | |
50 mg | In stock | $ 1,360.00 | |
100 mg | In stock | $ 1,830.00 |
Description | DAPK-IN-2 (WAY-380496) is a DAPK inhibitor. DAPK-IN-2 has potential anticancer activity, regulates autophagy and can be used to study cerebral infarction and ischemic diseases. |
In vitro |
DAPK-IN-2 (10 μM) inhibits DAPK3 by 36%.[1] DAPK-IN-2 (1 μM) inhibits DAPK3 by 14%.[1 |
Synonyms | WAY-380496 |
Molecular Weight | 310.3 |
Formula | C17H14N2O4 |
CAS No. | 304000-05-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
DAPK-IN-2 304000-05-3 Apoptosis DAPK WAY380496 WAY-380496 WAY 380496 inhibitor inhibit